{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:13:23Z","timestamp":1788567203732,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120480","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:10:57Z","timestamp":1752567057000},"page":"120480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol"],"prefix":"10.1016","volume":"578","author":[{"given":"Prince S.","family":"Gameli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayema","family":"Taoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagiulia Di","family":"Trana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio P.","family":"Tronconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco P.","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120480_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2019.00109","article-title":"New synthetic cannabinoids metabolism and strategies to best identify optimal marker metabolites","volume":"7","author":"Diao","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.cca.2025.120480_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-024-00226-y","article-title":"An emerging trend in novel psychoactive substances (NPSs): designer THC","volume":"6","author":"Caprari","year":"2024","journal-title":"J Cannabis Res"},{"key":"10.1016\/j.cca.2025.120480_b0015","unstructured":"EMCDDA, Hexahydrocannabinol (HHC) and related substances, (2023). https:\/\/doi.org\/10.2810\/852912."},{"key":"10.1016\/j.cca.2025.120480_b0020","doi-asserted-by":"crossref","DOI":"10.1017\/ipm.2024.3","article-title":"HHC-induced psychosis: a case series of psychotic illness triggered by a widely available semisynthetic cannabinoid","author":"O\u2019Mahony","year":"2024","journal-title":"Ir J Psychol Med"},{"key":"10.1016\/j.cca.2025.120480_b0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365513.2024.2340039","article-title":"Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing \u2013 focus on HHC, HHC-P, HHC-O and HHC-H","volume":"84","author":"Helander","year":"2024","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cca.2025.120480_b0030","doi-asserted-by":"crossref","unstructured":"A. Di Trana, D. Berardinelli, E. Montanari, P. Berretta, G. Basile, M.A. Huestis, et al., Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances, International Journal of Molecular Sciences 2022, Vol. 23, Page 14619 23 (2022) 14619. https:\/\/doi.org\/10.3390\/IJMS232314619.","DOI":"10.3390\/ijms232314619"},{"key":"10.1016\/j.cca.2025.120480_b0035","year":"2024","journal-title":"Expert Committee on Drug Dependence (ECDD)"},{"key":"10.1016\/j.cca.2025.120480_b0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dta.3519","article-title":"Hexahydrocannabinol and closely related semi-synthetic cannabinoids: a comprehensive review","volume":"16","author":"Ujv\u00e1ry","year":"2024","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.cca.2025.120480_b0045","doi-asserted-by":"crossref","unstructured":"F. Russo, M.A. Vandelli, G. Biagini, M. Schmid, L. Luongo, M. Perrone, et al., Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC), Scientific Reports 2023 13:1 13 (2023) 1\u201311. https:\/\/doi.org\/10.1038\/s41598-023-38188-5.","DOI":"10.1038\/s41598-023-38188-5"},{"key":"10.1016\/j.cca.2025.120480_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28176434","article-title":"Saturated Cannabinoids: update on synthesis strategies and biological studies of these Emerging Cannabinoid analogs","volume":"28","author":"Docampo-Palacios","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2025.120480_b0055","first-page":"622","article-title":"Hexahydrocannabinol on the light Cannabis Market","author":"Casati","year":"2024","journal-title":"The Latest \u201cnew\u201d Entry, Https:\/\/home.liebertpub.com\/can 9"},{"key":"10.1016\/j.cca.2025.120480_b0060","article-title":"In vitro activation of the CB1 receptor by the semi-synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC-O) and hexahydrocannabiphorol (HHC-P)","author":"Persson","year":"2024","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.cca.2025.120480_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-58845-7","article-title":"Hexahydrocannabinol (HHC) and \u03949-tetrahydrocannabinol (\u03949-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling","volume":"14","author":"Durydivka","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.cca.2025.120480_b0070","doi-asserted-by":"crossref","first-page":"e9711","DOI":"10.1002\/rcm.9711","article-title":"Identification and quantification of both isomers of hexahydrocannabinol, (9R)-hexahydrocannabinol and (9S)-hexahydrocannabinol, in three different matrices by mass spectrometry","volume":"38","author":"Bottinelli","year":"2024","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.cca.2025.120480_b0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/dta.3570","article-title":"Quantification of (9R)- and (9S)-hexahydrocannabinol (HHC) via GC\u2013MS in serum\/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva","volume":"16","author":"H\u00f6fert","year":"2024","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.cca.2025.120480_b0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jat\/bkae030","article-title":"Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases","volume":"48","author":"Kronstrand","year":"2024","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cca.2025.120480_b0085","doi-asserted-by":"crossref","unstructured":"A. Di Trana, A. Di Giorgi, G. Sprega, J. Carlier, G. Kobidze, E. Montanari, et al., Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study, Pharmaceuticals 2024, Vol. 17, Page 249 17 (2024) 249. https:\/\/doi.org\/10.3390\/PH17020249.","DOI":"10.3390\/ph17020249"},{"key":"10.1016\/j.cca.2025.120480_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115918","article-title":"The first LC-MS\/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine","volume":"240","author":"Kobidze","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2025.120480_b0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0091-3057(91)90359-A","article-title":"Comparative in vitro metabolism of the cannabinoids","volume":"40","author":"Harvey","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.cca.2025.120480_b0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/14690667231200139","article-title":"Identification of human hexahydrocannabinol metabolites in urine","volume":"29","author":"Schirmer","year":"2023","journal-title":"Eur J Mass Spectrom (chichester)"},{"key":"10.1016\/j.cca.2025.120480_b0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/jat\/bkad079","article-title":"Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC-HRMS-MS","volume":"47","author":"Manier","year":"2023","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cca.2025.120480_b0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/00365513.2024.2333023","article-title":"LC-MS\/MS analysis of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) and 11-hydroxy-hexahydrocannabinol (HHC-OH) for verification of hexahydrocannabinol (HHC) intake","volume":"84","author":"Pettersson-Pablo","year":"2024","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cca.2025.120480_b0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","journal-title":"J Cheminform"},{"key":"10.1016\/j.cca.2025.120480_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122740","article-title":"In silico prediction, LC-HRMS\/MS analysis, and targeted\/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites","volume":"235","author":"Di Trana","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.cca.2025.120480_b0125","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.cca.2025.120480_b0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aca.2008.04.043","article-title":"Interferences and contaminants encountered in modern mass spectrometry","volume":"627","author":"Keller","year":"2008","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cca.2025.120480_b0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.compbiomed.2019.01.008","article-title":"In silico approaches and tools for the prediction of drug metabolism and fate: a review","volume":"106","author":"Kazmi","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.cca.2025.120480_b0140","doi-asserted-by":"crossref","unstructured":"M. Boyce, K.A. Favela, J.A. Bonzo, A. Chao, L.E. Lizarraga, L.R. Moody, et al., J.F. Wambaugh, Identifying xenobiotic metabolites with in silico prediction tools and LCMS suspect screening analysis, Frontiers in Toxicology 5 (2023) 1051483. https:\/\/doi.org\/10.3389\/FTOX.2023.1051483\/BIBTEX.","DOI":"10.3389\/ftox.2023.1051483"},{"key":"10.1016\/j.cca.2025.120480_b0145","first-page":"1","article-title":"Metabolism and detection of designer benzodiazepines; a systematic review","author":"Gameli","year":"2024","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.cca.2025.120480_b0150","first-page":"1","article-title":"Identifying metabolites of new psychoactive substances using in silico prediction tools","author":"Pelletier","year":"2025","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cca.2025.120480_b0155","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/17512433.2022.2148655","article-title":"Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy","volume":"15","author":"Bardhi","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.cca.2025.120480_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113113","article-title":"Enantioselectivity in drug pharmacokinetics and toxicity: Pharmacological relevance and analytical methods","volume":"26","author":"Coelho","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2025.120480_b0165","article-title":"Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples","author":"Lindbom","year":"2024","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.cca.2025.120480_b0170","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkae022","article-title":"Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography-high-resolution tandem mass spectrometry","volume":"48","author":"Pitterl","year":"2024","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cca.2025.120480_b0175","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.3390\/molecules29143440","article-title":"QuEChERS Extraction and simultaneous quantification in GC-MS\/MS of hexahydrocannabinol Epimers and their metabolites in whole blood, urine, and Oral fluid","volume":"29","author":"Di Trana","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2025.120480_b0180","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11101-015-9438-9","article-title":"Biotransformation of tetrahydrocannabinol","volume":"15","author":"Akhtar","year":"2016","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.cca.2025.120480_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114841","article-title":"Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. application to patients treated with medical cannabis","author":"Lo Faro","year":"2022","journal-title":"J Pharm Biomed Anal 217"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125003596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125003596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:32:42Z","timestamp":1777462362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125003596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["S0009898125003596"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120480","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120480"}}